Exudative age‐related macular degeneration lesion components predicting microperimetric retinal sensitivity during anti‐vascular endothelial growth factor treatment
Acta Ophthalmologica · 2024
DOI: 10.1111/aos.15707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Henrik Bygglin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Cysts, Macular Degeneration, Wet Macular Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To analyse the effect of exudative age‐related macular degeneration (eAMD) lesion components on retinal sensitivity during anti‐vascular endothelial growth factor treatment.
Methods
Visual acuity, fluorescein and indocyanine green (ICG) angiographies, autofluorescence images, microperimetries and optical coherence tomographies (OCTs) of 24 eyes of 24 patients were prospectively analysed in a 2‐year study of pro‐re‐nata bevacizumab treatment for eAMD. Microperimetries were aligned with the OCTs, angiographies and autofluorescence images. Thicknesses of the neuroretina, pigment epithelial (RPE) elevation, neuroepithelial detachment (NED), subretinal tissue (SRT) and cystic intraretinal fluid were measured under each stimulus site, and areas of type 1 and type 2 macular neovascularizations (MNVs), ICG plaque, haemorrhage and RPE atrophy were identified. The effects and predictive values of lesion components on retinal sensitivity were analysed with multivariate mixed linear models for repeated measurements.
Results
The overall microperimetric retinal sensitivity increased during the first year (from 10.1 dB at baseline to 11.9 dB at 1 year; p = 0.021, Wilcoxon signed ranks), but remained the same during the second year (11.5 dB, p = 0.301). The baseline lesion components most strongly predicting deteriorated sensitivity at 1 year were RPE atrophy, the area of Type 2 MNV, intraretinal cysts, haemorrhage, Type 1 MNV and retinal thickening >350 μm. NED and RPE elevation had only small effects. At 2 years, the predictive values of the baseline lesion components remained quite unchanged.
Conclusion
The most powerful predictors of retinal sensitivity loss during 2 years of treatment were RPE atrophy, areas of haemorrhage, the area of MNVs, intraretinal cysts and SRT. RPE elevation and NED had lesser effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Insurance Science, Tampere University, Tampere, Finland.
ORCID-Profile: Henrik Bygglin
Zitieren
APA
Bygglin, H., Immonen, I., Luoma, A., & Hautamäki, A. (2024). Exudative age‐related macular degeneration lesion components predicting microperimetric retinal sensitivity during anti‐vascular endothelial growth factor treatment. Acta Ophthalmologica. https://doi.org/10.1111/aos.15707
Vancouver
Bygglin H, Immonen I, Luoma A, Hautamäki A. Exudative age‐related macular degeneration lesion components predicting microperimetric retinal sensitivity during anti‐vascular endothelial growth factor treatment. Acta Ophthalmologica. 2024. doi:10.1111/aos.15707
BibTeX
@article{Bygglin2024,
author = {Bygglin, Henrik and Immonen, Ilkka and Luoma, Arto and Hautamäki, Asta},
title = {Exudative age‐related macular degeneration lesion components predicting microperimetric retinal sensitivity during anti‐vascular endothelial growth factor treatment},
journal = {Acta Ophthalmologica},
year = {2024},
doi = {10.1111/aos.15707}
}
EUVIMED